Mouthpiece
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
The broken lines in the drawings are included for the purpose of illustrating environment and form no part of the claimed design.
Claims
The ornamental design for a mouthpiece, as shown and described.
D412978 | August 17, 1999 | Cameron |
D433502 | November 7, 2000 | Rand |
D492771 | July 6, 2004 | King et al. |
D492994 | July 13, 2004 | King et al. |
D493222 | July 20, 2004 | King et al. |
D543273 | May 22, 2007 | Young et al. |
D560793 | January 29, 2008 | Pearl et al. |
D591856 | May 5, 2009 | Lulla et al. |
D596739 | July 21, 2009 | Ng et al. |
7726314 | June 1, 2010 | Ming |
000688023-0001 | May 2007 | EM |
000688023-0002 | May 2007 | EM |
000688023-0003 | May 2007 | EM |
000688023-0004 | May 2007 | EM |
000688023-0005 | May 2007 | EM |
000688023-0006 | May 2007 | EM |
000688023-0007 | May 2007 | EM |
000688023-0008 | May 2007 | EM |
000688023-0009 | May 2007 | EM |
000688023-0010 | May 2007 | EM |
000688023-0011 | May 2007 | EM |
000688023-0012 | May 2007 | EM |
000688023-0013 | May 2007 | EM |
000688023-0014 | May 2007 | EM |
000688023-0015 | May 2007 | EM |
000688023-0016 | May 2007 | EM |
000688023-0017 | May 2007 | EM |
000688023-0018 | May 2007 | EM |
000688023-0019 | May 2007 | EM |
000688023-0020 | May 2007 | EM |
000688023-0021 | May 2007 | EM |
000688023-0022 | May 2007 | EM |
000688023-0023 | May 2007 | EM |
000688023-0024 | May 2007 | EM |
000688023-0025 | May 2007 | EM |
000688023-0026 | May 2007 | EM |
000688023-0027 | May 2007 | EM |
000688023-0028 | May 2007 | EM |
D1296192 | March 2007 | JP |
D1296193 | March 2007 | JP |
3001971220000 | April 1997 | KR |
3003630260001 | September 2004 | KR |
433889 | February 1989 | TW |
500591 | December 2001 | TW |
495327 | November 2002 | TW |
495328 | November 2002 | TW |
D111283 | July 2004 | TW |
D122108 | September 2006 | TW |
2006097745 | September 2006 | WO |
2007028992 | March 2007 | WO |
2008023019 | February 2008 | WO |
- U.S. Appl. No. 29/277,858, filed Mar. 12, 2007.
- U.S. Appl. No. 12/377,412, filed Feb. 13, 2009.
Type: Grant
Filed: Aug 15, 2008
Date of Patent: Jun 19, 2012
Assignee: Glaxo Group Limited (Greenford Middlesex)
Inventors: Gregor John McLennan Anderson (Ware), Gary Thomas Crosby (Ware), Philip William Farr (Ware), Joseph Paul Marino (Ware), Mark Digby Teucher (Bristol), James Anthony West (Bristol)
Primary Examiner: Ian Simmons
Assistant Examiner: Charles Hanson
Attorney: James P. Risk
Application Number: 29/322,977